LOVTAP
From 2009.igem.org
(11 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
+ | {{EPF-Lausanne09}} | ||
+ | |||
+ | <div CLASS="epfltrick">__TOC__ | ||
+ | </div> | ||
+ | <div CLASS="epfl09"> | ||
==To get== | ==To get== | ||
- | + | <font size=3> '''URGENT: get starting material''' </font size> | |
<br><i><font size=3> in vitro </font size></i> | <br><i><font size=3> in vitro </font size></i> | ||
- Sequence of the 12 mutant fusion proteins or LOV domain AND TrpR (separately) => [http://www.ncbi.nlm.nih.gov/ Pubmed] | - Sequence of the 12 mutant fusion proteins or LOV domain AND TrpR (separately) => [http://www.ncbi.nlm.nih.gov/ Pubmed] | ||
- | <br> - Purification kit | + | <br> - Purification kit&Digestion assay protocol => find the purification protocols etc. in the supplementary material, not by asking the authors |
- | + | ||
<br> - LED/light sources or photometer | <br> - LED/light sources or photometer | ||
<br> - Calmodulin kit or stuffs for protection assay | <br> - Calmodulin kit or stuffs for protection assay | ||
Line 12: | Line 16: | ||
<i><font size=3> in vivo </font size></i> | <i><font size=3> in vivo </font size></i> | ||
- | <br> - Inducible promoter | + | <br> - Inducible promoter: IPTG or Lac repressor |
- | <br> - Reporter cassette mCherry or RFP | + | <br> - Reporter cassette: mCherry or RFP |
==To do: theory== | ==To do: theory== | ||
Line 19: | Line 23: | ||
<span style="color:grey">letter :[[Media:letter_T.R.Sosnick.pdf]] | <span style="color:grey">letter :[[Media:letter_T.R.Sosnick.pdf]] | ||
+ | |||
+ | <i><font size=3> in vitro </font size></i> | ||
<i><font size=3> in vivo </font size></i> | <i><font size=3> in vivo </font size></i> | ||
Line 28: | Line 34: | ||
<br> Summary of what characterizes E.Coli Trp repressor : [[Media:The_tryptophan_biosynthetic_pathway.pdf]] | <br> Summary of what characterizes E.Coli Trp repressor : [[Media:The_tryptophan_biosynthetic_pathway.pdf]] | ||
<br> One good article : [[RNA-based_regulation_of_genes_of_tryptophan_synthesis_an_degradation.pdf]] | <br> One good article : [[RNA-based_regulation_of_genes_of_tryptophan_synthesis_an_degradation.pdf]] | ||
- | <br> | + | <br> Protein sequence from NCBI : [[Media:Sequence_du_Trp_repressor.txt]] |
<br> Design a biobrick that coexpresses LOVTAP and mCherry (after Trp operon) when LOVTAP bind the Trp operon. Design a switch on/off read out. | <br> Design a biobrick that coexpresses LOVTAP and mCherry (after Trp operon) when LOVTAP bind the Trp operon. Design a switch on/off read out. | ||
Line 42: | Line 48: | ||
: Trp has to be added | : Trp has to be added | ||
- | ;- Do a mutational assay to change or enhance specificity of LOVTAP: | + | ;- Do a mutational assay to change or enhance specificity of LOVTAP: |
- | : | + | :Directed mutational assay: Insert mutation in specific sites thanks to the known structure of LOVTAP (already modeled on computer) |
:Indirect mutational assay: Random mutations, then selection of the "right" protein according to a set of selected conditions | :Indirect mutational assay: Random mutations, then selection of the "right" protein according to a set of selected conditions | ||
+ | : <i>''' In vivo:'''</i> Evolved mutational assay: LovTap inhibit a killer gene, so the more the lovtap affinity for DNA is high the more likely cells will survive (simulation of evolutionnary selection) | ||
+ | :-> Other in vitro techniques: SELEX | ||
Line 53: | Line 61: | ||
- | + | </div> | |
- | + | <div CLASS="epfl09bouchon"></div> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Latest revision as of 12:41, 5 July 2009
Contents |
To get
URGENT: get starting material
in vitro
- Sequence of the 12 mutant fusion proteins or LOV domain AND TrpR (separately) => [http://www.ncbi.nlm.nih.gov/ Pubmed]
- Purification kit&Digestion assay protocol => find the purification protocols etc. in the supplementary material, not by asking the authors
- LED/light sources or photometer
- Calmodulin kit or stuffs for protection assay
in vivo
- Inducible promoter: IPTG or Lac repressor
- Reporter cassette: mCherry or RFP
To do: theory
- - Write an e-mail to Strickland et al to ask Basile first shot; I think we could then look at it all together
letter :Media:letter_T.R.Sosnick.pdf
in vitro
in vivo
- - Find the exact genetic circuit for Trp repressor Nath
An interesting course on TrpR and Trp operon: [http://www2.hawaii.edu/~scallaha/SMCsite/475%20Lectures/475Lecture34.pdf TrpR]
- - Biobricks
Look for a (or many) paper(s) that characterizes E.Coli Trp repressor, and find the Trp operon sequence Mél
Summary of what characterizes E.Coli Trp repressor : Media:The_tryptophan_biosynthetic_pathway.pdf
One good article : RNA-based_regulation_of_genes_of_tryptophan_synthesis_an_degradation.pdf
Protein sequence from NCBI : Media:Sequence_du_Trp_repressor.txt
Design a biobrick that coexpresses LOVTAP and mCherry (after Trp operon) when LOVTAP bind the Trp operon. Design a switch on/off read out.
To do: wet lab
in vitro
- - Redo the experiment they did in the LOVTAP article
!!! Major problem, the conformational change of LOVTAP is weak and the protection assay results show a small difference of LOVTAP binding on DNA between drak state and light state !!! ----> try to improve this
- Express and purify mutants
- is flavin indispensable??
- Trp has to be added
- - Do a mutational assay to change or enhance specificity of LOVTAP
- Directed mutational assay: Insert mutation in specific sites thanks to the known structure of LOVTAP (already modeled on computer)
- Indirect mutational assay: Random mutations, then selection of the "right" protein according to a set of selected conditions
- In vivo: Evolved mutational assay: LovTap inhibit a killer gene, so the more the lovtap affinity for DNA is high the more likely cells will survive (simulation of evolutionnary selection)
- -> Other in vitro techniques: SELEX
in vivo
- Express LOVTAP under control of an inducible promoter
- Link a reporter cassette with TrpR binding domain
</div>